2.Small-cell carcinoma of the ovary, hypercalcemic type: A report of two cases and review of related literature
Almaira S. Pagayao ; Jericho Thaddeus P. Luna
Philippine Journal of Obstetrics and Gynecology 2024;48(3):190-196
Small-cell carcinoma of the ovary, hypercalcemic type (SCCOHT), is a rare and aggressive type of ovarian cancer. It generally presents in younger patients, is diagnosed at an advanced stage, and is associated with a dismal prognosis. Due to its rarity and morphologic similarity to more common ovarian tumors, diagnosis may be a challenge. A high index of suspicion followed by appropriate immunohistochemistry stains performed by an expert pathologist is essential to diagnosis. Two cases of SCCOHT are presented: 21 years old with rapidly progressive Stage IIIA1i disease who underwent surgery and succumbed to the illness after 3 months before adjuvant treatment could be given, and a 49 years old with Stage IIIB disease with tumor progression who is on adjuvant chemotherapy and apparently well, 21 months after her first symptoms appeared. Related literature is presented and compared to the features of the index cases. Diagnosis and treatment options are also discussed briefly.
ovarian cancer
;
ovarian neoplasms
3.Role and clinical application of next-generation sequencing (NGS) for ovarian cancer.
Myong Cheol LIM ; Leslie M RANDALL
Journal of Gynecologic Oncology 2017;28(4):e51-
No abstract available.
Ovarian Neoplasms*
4.An immunohistochemical evaluation of c-erbB-2 expression in epithelial ovarian cancer.
Kyung Tai KIM ; Sam Hyun CHO ; Youn Yeoung HWANG ; Hyung MOON ; Jai Auk LEE ; Young Hye KO ; Jung Dal LEE
Korean Journal of Obstetrics and Gynecology 1993;36(8):3334-3342
No abstract available.
Ovarian Neoplasms*
5.Three ongoing intraperitoneal chemotherapy trials in ovarian cancer.
Journal of Gynecologic Oncology 2012;23(2):75-77
No abstract available.
Ovarian Neoplasms
6.Clinical significance of postoperative CA-125 level after primary cytoreductive surgery in ovarian cancer.
Journal of Gynecologic Oncology 2008;19(4):279-279
No abstract available.
Ovarian Neoplasms
7.Clinical significance of postoperative CA-125 level after primary cytoreductive surgery in ovarian cancer.
Journal of Gynecologic Oncology 2008;19(4):279-279
No abstract available.
Ovarian Neoplasms
8.Management of Advanced Epithelial Ovarian Cancer.
Korean Journal of Obstetrics and Gynecology 1999;42(8):1647-1654
No abstract available.
Ovarian Neoplasms*
9.A Short-Term In-Vitro Chemosensitivity Test for Ovarian Cancer: Nuclear Damage Assay.
Young Tak KIM ; Kwan Ja JI ; Yong Man KIM ; Joo Hyun NAM ; Jung Eun MOK
Korean Journal of Gynecologic Oncology and Colposcopy 1997;8(1):47-54
No abstract available.
Ovarian Neoplasms*
10.Do we need a better marker for successful ovarian cancer surgery?.
Journal of Gynecologic Oncology 2017;28(1):e21-
No abstract available.
Ovarian Neoplasms*
Result Analysis
Print
Save
E-mail